HUP0400976A2 - VII-es faktor polipeptideket és XI-es faktor polipeptideket tartalmazó gyógyszerészeti összetételek - Google Patents

VII-es faktor polipeptideket és XI-es faktor polipeptideket tartalmazó gyógyszerészeti összetételek

Info

Publication number
HUP0400976A2
HUP0400976A2 HU0400976A HUP0400976A HUP0400976A2 HU P0400976 A2 HUP0400976 A2 HU P0400976A2 HU 0400976 A HU0400976 A HU 0400976A HU P0400976 A HUP0400976 A HU P0400976A HU P0400976 A2 HUP0400976 A2 HU P0400976A2
Authority
HU
Hungary
Prior art keywords
factor
polypeptides
pharmaceutical composition
factor vii
vii
Prior art date
Application number
HU0400976A
Other languages
English (en)
Inventor
Rasmus Rojkjaer
Original Assignee
Novo Nordisk Health Care Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk Health Care Ag filed Critical Novo Nordisk Health Care Ag
Publication of HUP0400976A2 publication Critical patent/HUP0400976A2/hu
Publication of HUP0400976A3 publication Critical patent/HUP0400976A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4846—Factor VII (3.4.21.21); Factor IX (3.4.21.22); Factor Xa (3.4.21.6); Factor XI (3.4.21.27); Factor XII (3.4.21.38)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

A találmány összetételekre vonatkozik, melyek VII-es faktor vagy VII-es faktor rokon polipeptideket és XI-es faktor vagy XI-es faktor rokonpolipeptideket tartalmaznak, amelyeket a vérzési események kezelésérelehet felhasználni. Ó
HU0400976A 2001-07-20 2002-07-19 Pharmaceutical composition comprising factor vii polypeptides and factor xi polypeptides HUP0400976A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200101127 2001-07-20
PCT/DK2002/000505 WO2003007983A1 (en) 2001-07-20 2002-07-19 Pharmaceutical composition comprising factor vii polypeptides and factor xi polypeptides

Publications (2)

Publication Number Publication Date
HUP0400976A2 true HUP0400976A2 (hu) 2004-08-30
HUP0400976A3 HUP0400976A3 (en) 2006-01-30

Family

ID=8160632

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0400976A HUP0400976A3 (en) 2001-07-20 2002-07-19 Pharmaceutical composition comprising factor vii polypeptides and factor xi polypeptides

Country Status (16)

Country Link
EP (1) EP1411973A1 (hu)
JP (1) JP2004534855A (hu)
KR (1) KR20040015821A (hu)
CN (1) CN1304050C (hu)
AU (1) AU2002354846B2 (hu)
BR (1) BR0211256A (hu)
CA (1) CA2452677A1 (hu)
CZ (1) CZ200439A3 (hu)
HU (1) HUP0400976A3 (hu)
IL (1) IL159622A0 (hu)
MX (1) MXPA04000415A (hu)
NO (1) NO20040235L (hu)
PL (1) PL369077A1 (hu)
RU (1) RU2298416C2 (hu)
WO (1) WO2003007983A1 (hu)
ZA (1) ZA200400012B (hu)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100411684C (zh) 1999-07-14 2008-08-20 诺沃挪第克健康护理股份公司 FVIIa或组织因子拮抗剂在调节基因表达和细胞迁移或趋化中的应用
ES2381110T3 (es) 2003-09-09 2012-05-23 Novo Nordisk Health Care Ag Polipéptidos de factor VII de coagulación
BRPI0416461A (pt) * 2003-11-20 2007-03-06 Novo Nordisk Healthcare Ag método para o tratamento de episódios de sangramento, formulação farmacêutica, e, uso de um polipeptìdeo fxi
WO2005074974A1 (en) * 2004-02-05 2005-08-18 Novo Nordisk Health Care Ag Use of factor viia for treating late complications of trauma
WO2006128497A1 (en) * 2005-06-01 2006-12-07 Novo Nordisk A/S Pharmaceutical formulation of factor xi
JP5739816B2 (ja) 2008-12-19 2015-06-24 バクスター・インターナショナル・インコーポレイテッドＢａｘｔｅｒ Ｉｎｔｅｒｎａｔｉｏｎａｌ Ｉｎｃｏｒｐ０Ｒａｔｅｄ Ｔｆｐｉインヒビターおよび使用法
NZ603028A (en) 2010-03-19 2014-11-28 Baxter Healthcare Sa Tfpi inhibitors and methods of use
AU2011313505B2 (en) * 2010-10-06 2015-09-17 Medimmune Limited Factor II and fibrinogen for treatment of haemostatic disorders
KR102263685B1 (ko) 2012-03-21 2021-06-11 다케다 야쿠힌 고교 가부시키가이샤 Tfpi 저해제 및 사용 방법
EP3099171A4 (en) * 2014-01-31 2017-08-09 Dana-Farber Cancer Institute, Inc. Dihydropteridinone derivatives and uses thereof
WO2016201370A1 (en) 2015-06-12 2016-12-15 Dana-Farber Cancer Institute, Inc. Combination therapy of transcription inhibitors and kinase inhibitors
CR20180336A (es) 2015-11-25 2018-08-06 Dana Farber Cancer Inst Inc Inhibidores de bromodominio bivalentes y usos de los mismos
US11958911B2 (en) 2017-02-10 2024-04-16 Shanghai Benemae Pharmaceutical Anti-coagulation factor XI antibody

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59116213A (ja) * 1982-12-24 1984-07-05 Unitika Ltd エアゾ−ル組成物
JPH0780783B2 (ja) * 1985-11-26 1995-08-30 ノボ ノルディスク アクティーゼルスカブ 出血障害の治療のための第▲ＶＩＩ▼ａ因子を含有する治療組成物
US5580560A (en) * 1989-11-13 1996-12-03 Novo Nordisk A/S Modified factor VII/VIIa
FR2676231A1 (fr) * 1991-05-07 1992-11-13 Aetsrn Concentre de facteur xi de la coagulation sanguine a haute activite specifique, approprie a usage therapeutique et son procede de preparation.
EP2253703A1 (en) * 2000-09-13 2010-11-24 Novo Nordisk Health Care AG Human coagulation factor VII variants

Also Published As

Publication number Publication date
CA2452677A1 (en) 2003-01-30
AU2002354846B2 (en) 2007-08-02
KR20040015821A (ko) 2004-02-19
PL369077A1 (en) 2005-04-18
NO20040235L (no) 2004-03-17
WO2003007983A1 (en) 2003-01-30
CN1304050C (zh) 2007-03-14
MXPA04000415A (es) 2004-11-22
RU2298416C2 (ru) 2007-05-10
CN1556710A (zh) 2004-12-22
RU2004105031A (ru) 2005-04-20
ZA200400012B (en) 2004-08-17
JP2004534855A (ja) 2004-11-18
EP1411973A1 (en) 2004-04-28
HUP0400976A3 (en) 2006-01-30
IL159622A0 (en) 2004-06-01
CZ200439A3 (cs) 2005-03-16
BR0211256A (pt) 2004-07-27

Similar Documents

Publication Publication Date Title
HUP0303143A2 (hu) A VII-es faktor és a IX-es faktor polipeptidek kombinált alkalmazása
IL159076A0 (en) Hiv protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
IL232501A (en) Peptide or polypeptide-resistant protein analogs and their uses
PL375621A1 (en) Pharmaceutical compositions comprising flavonoids and menthol
DE60239648D1 (de) Pharmazeutische Zusammensetzungen zur Behandlung von Asthma
TW200505875A (en) Novel compounds
GEP20063741B (en) Nonaryl-Heterocyclic NMDA/NR2B Antagonists
HUP0402497A3 (en) Pharmaceutical compositions containing two activ ingredients and their uses
IL203923A (en) Benzamide compounds, pharmaceutical compositions comprising them, use thereof in the preparation of medicaments and as medicaments and processes for the preparation of such compounds
HUP0400976A2 (hu) VII-es faktor polipeptideket és XI-es faktor polipeptideket tartalmazó gyógyszerészeti összetételek
DE60120712D1 (en) Kallikrein gen
AP1787A (en) Novel perindopril salt and pharmaceutical compositions containing same.
TW200630343A (en) 2-Alkoxy-3,4,5-trihydroxy-alkylamides, preparation thereof, compositions containing them and use thereof
SI1411921T1 (sl) Farmacevtski sestavki, ki vsebujejo terbinafin, in njihova uporaba
MXPA03010158A (es) Sulfonamidas.
DE60209152D1 (de) Pharmazeutische zusammensetzung, umfassend gabapentin oder ein analogon davon und ein alpha-aminoamid
MXPA02010458A (es) Peptido modulador del receptor de trombopoyetina.
MXPA03010684A (es) Peptidos y el uso de los mismos para oscurecer la piel.
HRP20070291T3 (en) Pharmaceutical composition comprising a zinc-hyaluronate complex for the treatment of multiple sclerosis
HUP0400438A3 (en) Broadspectrum 2-amino-benzoxazole-6-sulfonamides, their use as hiv protease inhibitor and pharmaceutical compositions containing them
MXPA03010683A (es) Composicion que contiene un peptido y un pigmento y el uso del mismo para oscurecer la piel.
TR200402070T4 (tr) Siklobüten-dion türevleri ve bunların damar sertliği tedavisinde kullanımı
HUP0204554A2 (en) Endoparasiticidal composition, preparation and use thereof
HUP0401644A3 (en) Aminobenzoephenones, pharmaceutical compositions containing them and use thereof
AR047282A1 (es) Composicion de esmalte o composicion de metales preciosos, aplicacion de dicha composicion, y calcomania que contiene a dicha composicion. composicion de esmalte o composicion de metales preciosos, aplicacion de dicha composicion, y calcomanias que contiene a dicha composicion

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees